Respiri brings wheezo device and app to US market
pharmaphorum
AUGUST 2, 2022
Australian digital health company Respiri has rolled out its wheezo device, app and healthcare monitoring portal at Michigan Children’s Hospital, the first US customer for the technology. Access is now working on integration work with Michigan’s electronic medical record (EMR) system.
Let's personalize your content